SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-055989
Filing Date
2021-04-28
Accepted
2021-04-28 07:30:48
Documents
6
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212513-1_def14a.htm DEF 14A 1126779
2 GRAPHIC lg_ymabstherap-4clr.jpg GRAPHIC 22175
3 GRAPHIC sg_thomasgad-bw.jpg GRAPHIC 5377
4 GRAPHIC tm212513d1_proxypxb-page1.jpg GRAPHIC 728328
5 GRAPHIC tm212513d1_proxypxf-page1.jpg GRAPHIC 1075654
6 GRAPHIC tm212513d1_proxypxi-page1.jpg GRAPHIC 1295550
  Complete submission text file 0001104659-21-055989.txt   5429268
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38650 | Film No.: 21861351
SIC: 2834 Pharmaceutical Preparations